Search

everythinglearnresearchcommunity

for

Search:↓

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Combining PRP with low-level laser therapy is better for hair growth than PRP alone.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

"Alpenta" effectively reduces hair loss and improves hair growth in women with telogen effluvium.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Botulinum toxin A does not significantly improve hair density or thickness in androgenetic alopecia.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Temporal triangular alopecia in infants is mostly seen in males at birth, with unique features that help with diagnosis.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

Specific RNA patterns are linked to alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Blocking certain proteins on immune cells may help treat alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Art therapy may help reduce anxiety and depression in people with Alopecia Areata.